Home
 /
Papers
 /
Genomics
 /
In vivo interrogation of transcriptional and epigenetic regulators of lung epithelial regeneration
Preprint
Open access
V1
Top 1% · Validated by QED

In vivo interrogation of transcriptional and epigenetic regulators of lung epithelial regeneration

Dawei Sun, Daisy A. Hoagland, Daniel Strebinger +7 more
March 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.03.13.711474
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Genomics this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By delivering the first pooled in vivo CRISPR screen in regenerating lung epithelium, this work identifies Kat8/NSL as an essential epigenetic repair dependency and resolves the transcriptional logic governing pathological, fibrosis-linked epithelial remodeling.

QED claims analysis

Summary

Development of SAGE, an AAV-based in vivo genetic screening platform, enables systematic identification of transcriptional and epigenetic regulators of alveolar repair, revealing that histone acetylation through the Kat8-NSL complex is essential for AT2-mediated regeneration, and that inflammatory signaling through NF-κB drives AT2 cells into a pathological basaloid-like transitional state rather than a reparative trajectory, linking inflammation to maladaptive epithelial remodeling in lung injury.

See full analysis
Main Claim 1 –

SAGE Enables Efficient In Vivo Pooled Lung Genetic Screens

Supporting evidence

  • SAGE Achieves 78.5% In Vivo Protein-Level Gene Knockout
  • SAGE Low Multi-Infection Enables Single-Copy Perturbation Tracking
Main Claim 2 –

Histone Acetylation Regulators Are Essential for AT2 Alveolar Regeneration

Supporting evidence

  • Inhibiting Screen Hits Phenocopies Genetic Effects on AT2 Organoids
Main Claim 3 –

SAGE-Perturb-seq Enables In Vivo Single-Cell Perturbation Transcriptomics

Main Claim 4 –

Kat8 Regulates Alveolar Repair via NSL, Not MSL

Abstract

Effective alveolar repair after viral lung injury requires precise coordination of alveolar type 2 cell (AT2) proliferation and differentiation to restore lung function. To uncover causal regulators of this process in the native tissue environment, we developed SAGE (Stable Adeno-Associated Virus Genomic IntEgration), an engineered AAV system that enables high-throughput in vivo genetic interrogation. SAGE supports both bulk phenotypic screening (SAGE-Perturb) and single-cell transcriptomic profiling (SAGE-Perturb-seq). Using this approach, we identified lysine acetyltransferase 8 (Kat8) as essential for epithelial repair following viral infection through the Non-Specific-Lethal (NSL) complex, and generated a time-resolved, high-resolution functional map of transcription factor knockouts during alveolar repair, revealing transcription factor dependences for distinct alveolar epithelial repair trajectories. This map further defined two independent AT2-derived transitional states: a reparative state, and a pathological state that is transcriptionally similar to the basaloid population observed in human pulmonary fibrosis. Disruption of transcription factors in the NF-κB pathway prevented the emergence of the pathological transitional state, linking inflammation and maladaptive epithelial remodeling. SAGE represents a versatile platform for functional genomics in vivo, with applications extending across respiratory biology and disease.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?